Managed Access Programs for CTL019, Tisagenlecleucel
NCT03601442
·
clinicaltrials.gov ↗
AVAILABLE
Status
INDUSTRY
Sponsor class
Conditions
Lymphoma
Leukemia
Off-label Indications
Interventions
BIOLOGICAL:
CTL019
Sponsor
Novartis Pharmaceuticals